Skip to main content
. 2019 Jun 28;4(1):119–131. doi: 10.1007/s41669-019-0154-z

Fig. 1.

Fig. 1

Medication treatment patterns during the observation period among TRD, non-TRD MDD, and non-MDD cohorts. MDD major depressive disorder, NDRIs norepinephrine-dopamine reuptake inhibitors, SNRIs serotonin-norepinephrine reuptake inhibitors, SSRIs selective serotonin reuptake inhibitors, TRD treatment-resistant depression